Table 11 Estimation of relative bioavailability values (RBV) of the 3 organic Fe sources¹

PI

0.114 ± 0.019^B

0.108 ± 0.019^B

0.122 ± 0.018^AB

0.137 ± 0.019^A

100

95 ± 9

106 ± 8

120 ± 8

0.02

TS

4.505 ± 0.845

4.221 ± 0.801

4.562 ± 0.773

4.918 ± 0.806

100

94 ± 15

101 ± 14

109 ± 14

0.34

Liver Fe

5.821 ± 2.513^B

9.228 ± 2.445^A

10.414 ± 2.387^A

10.883 ± 2.506^A

100

159 ± 24

179 ± 26

187 ± 26

< 0.0001

Liver SDH activity

0.108 ± 0.051

0.131 ± 0.049

0.137 ± 0.048

0.147 ± 0.050

100

121 ± 23

127 ± 23

136 ± 24

0.15

Heart SDH activity

0.254 ± 0.095^B

0.283 ± 0.091^AB

0.337 ± 0.091^AB

0.365 ± 0.093^A

100

111 ± 19

133 ± 19

144 ± 20

0.03

Kidney SDH activity

0.237 ± 0.111^B

0.327 ± 0.109^AB

0.424 ± 0.106^A

0.438 ± 0.111^A

100

138 ± 24

179 ± 28

185 ± 28

0.0007

Liver CAT activity

0.328 ± 0.123^C

0.508 ± 0.119^B

0.512 ± 0.119^AB

0.635 ± 0.122^A

100

155 ± 21

156 ± 21

194 ± 23

< 0.0001

Liver COX activity

2.236 ± 0.533

2.450 ± 0.519

2.410 ± 0.514

2.572 ± 0.522

100

112 ± 12

108 ± 12

115 ± 12

0.23

Liver SDH mRNA

0.073 ± 0.027^B

0.107 ± 0.027^A

0.117 ± 0.027^A

0.123 ± 0.027^A

100

147 ± 20

160 ± 21

169 ± 21

< 0.0001

Kidney SDH mRNA

0.054 ± 0.024^B

0.092 ± 0.023^A

0.094 ± 0.023^A

0.088 ± 0.024^A

100

170 ± 25

174 ± 26

160 ± 25

< 0.0001